n (%) | |
Clinical management | |
Hospital admission | 665 (63.8) |
Length of stay, days [IQR] | 1.73 [1.00, 3.00] |
ICU admission | 67 (10.1) |
Length of stay, days [IQR] | 3.00 [1.50, 6.50] |
Treatments | |
Antiepileptics | 17 (1.6) |
Antimicrobials | 80 (7.7) |
Acid suppression or antireflux medications | 160 (15.4) |
Nasogastric feeds | 16 (1.5) |
Intravenous fluids | 59 (5.7) |
Caffeine | 24 (2.3) |
Oxygen (low-flow nasal prongs, or high flow) | 29 (2.8) |
Positive pressure ventilation (CPAP or BiPAP) | 12 (1.2) |
CPR training offered | 140 (13.4) |
Complications | 162 (15.5) |
False positive testing | 127 (12.2) |
Non-clinically significant events on monitors | 43 (4.1) |
Intravenous extravasation | 2 (0.2) |
Significant surgical complications | 1 (0.1) |
Other | 11 (1.1) |
Diagnostic testing* | 855 (82.1) |
Consultations† | 440 (42.2) |
Clinical outcomes | |
Underlying diagnosis‡ | |
Serious | 79 (7.6) |
Non-serious | 412 (39.5) |
N/A (unexplained) | 551 (52.9) |
Recurrent event | 163 (15.6) |
During index visit | 113 (10.8) |
After discharge‡ | 65 (6.2) |
Return visit‡ | 216 (20.7) |
Return visit‡—related to BRUE | 92 (8.8) |
Rehospitalisation‡ | 64 (6.1) |
Death‡ | 1 (0.1) |
*Diagnostic testing included laboratory testing (bloodwork, urine or cerebral spinal fluid studies, imaging and ancillary testing).
†Consultations included evaluation by specialists or allied healthcare providers.
‡At or within 90 days of index presentation.
BiPAP, bilevel positive airway pressure; BRUE, brief resolved unexplained event; CPAP, continuous positive airway pressure; CPR, cardiopulmonary resuscitation; ICU, intensive care unit.